• Publications
  • Influence
Parathyroid carcinoma.
Parathyroid carcinoma is a rare tumor that is prone to recurrence and poor local-regional control. Despite advances in technologies that have shown promise for accurate diagnosis, the mainstay ofExpand
  • 254
  • 36
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY DISEASE STATE CLINICAL REVIEW: POSTOPERATIVE HYPOPARATHYROIDISM--DEFINITIONS AND MANAGEMENT.
Abbreviations: BID = bis in die DSPTC = diffuse sclerosing papillary thyroid cancer FNA = fine-needle aspiration HT = Hashimoto thyroiditis iPTH = intact parathyroid hormone 25OHD = 25-hydroxyExpand
  • 105
  • 6
Methylation status of genes in papillary thyroid carcinoma.
OBJECTIVES To determine the methylation status of gene promoter regions using methylation-specific polymerase chain reaction in genes encoding for thyrotropin receptor (TSHR), E-cadherin (ECAD),Expand
  • 62
  • 6
Binding of estrogen receptor with estrogen conjugated to bovine serum albumin (BSA)
BackgroundThe classic model of estrogen action requires that the estrogen receptor (ER) activates gene expression by binding directly or indirectly to DNA. Recent studies, however, strongly suggestExpand
  • 86
  • 5
A Phase II Trial of the Multitargeted Tyrosine Kinase Inhibitor Lenvatinib (E7080) in Advanced Medullary Thyroid Cancer
Purpose: Positive results of phase I studies evaluating lenvatinib in solid tumors, including thyroid cancer, prompted a phase II trial in advanced medullary thyroid carcinoma (MTC). ExperimentalExpand
  • 120
  • 5
  • PDF
Hypothyroidism in patients with multiple myeloma following treatment with thalidomide.
Thalidomide is used for the management of several diseases, including the treatment of patients with multiple myeloma who have relapsed(1–3). As the number of patients receiving thalidomide forExpand
  • 73
  • 4
Characterization of hyperparathyroidism in youth and adolescents: a literature review.
OBJECTIVES To systematically review the preoperative diagnostic modalities, surgical treatments, and glandular pathologies associated with primary hyperparathyroidism in children and adolescentsExpand
  • 32
  • 4
A phase 2 trial of lenvatinib (E7080) in advanced, progressive, radioiodine‐refractory, differentiated thyroid cancer: A clinical outcomes and biomarker assessment
Lenvatinib is an oral, multitargeted tyrosine kinase inhibitor of the vascular endothelial growth factor receptors 1 through 3 (VEGFR1‐VEGFR3), fibroblast growth factor receptors 1 through 4Expand
  • 109
  • 3
Incidence of Thyroid Carcinoma in Fluorodeoxyglucose Positron Emission Tomography-Positive Thyroid Incidentalomas
OBJECTIVE: Fluorodeoxyglucose (FDG) whole body positron emission tomography (PET) scan may show clinically occult second lesions. Such lesions in the thyroid are increasingly common. There areExpand
  • 68
  • 3
Effects of megestrol acetate on pituitary function and end-organ hormone secretion: a post hoc analysis of serum samples from a 12-week study in healthy older men.
BACKGROUND Megestrol acetate (MA) is a synthetic progestin commonly used to promote weight gain in malnourished older individuals. In small studies, MA administration has been associated with reducedExpand
  • 22
  • 2
...
1
2
3
4
5
...